San Diego-based Sequenom, a provider of genetic analysis products, said Tuesday that it has agreed to acquire the Center for Molecular Medicine (CMM), a clinical diagnostics laboratory based in Grand Rapids, Michigan. According to Sequenom, it will pay approximately $4.0M to acquire CMM, in addition to receiving a tax incentive valued at $20M over 12 years. CMM is a joint venture between Spectrum Health and Van Andel Research Institute.
Top NewsTuesday, September 23, 2008
Sequenom Acquires Diagnostics Lab